Immediate versus long-term effect of rituximab in recurrent focal segmental glomerulosclerosis.
Tobias N
TN
Meyer
Friedrich
F
Thaiss
Rolf A K
RA
Stahl
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation; D011507:Proteinuria / Q000517:prevention & control; D000069283:Rituximab; D055502:Secondary Prevention; D013997:Time Factors
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab